CClinicalTrials.gg
CompletedNCT03005509TQIUpdated Nov 27, 2019

Structured Trauma Quality Improvement Meetings at Four Trauma Centres in India

An interventional study of TQIM checklist in Major Trauma and Injuries Major, sponsored by Dr Gerard O'Reilly. Completed at 4 sites in India. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-11-27.

Sponsored by Dr Gerard O'Reilly · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
1,500
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

A prospective before-and-after study to evaluate the effect of implementing a Trauma Quality Improvement protocol on the process of Trauma Quality Improvement meetings and major trauma patient outcomes at four trauma centres in India.

Read the detailed description

This project will be conducted as a prospective before-and-after study at four major trauma centres in India, with the intervention occurring between pre- and post-intervention phases. Included in the study will be all patients presenting to any of the four trauma hospitals with a potentially life-threatening or limb-threatening injury. The intervention will be the introduction of a structured Trauma Quality Improvement Meeting (TQIM), using a checklist and training program. The primary outcome will be compliance with the TQIM checklist, measured as the proportion of discussed cases (trauma deaths) for which problems with care, preventability and corrective actions were discussed and / or agreed. The secondary outcomes will include in-hospital risk-adjusted mortality, hospital length of stay and time to emergency surgery. Data collection will occur at all meetings at the four trauma hospitals at which trauma deaths are discussed. Data will also be collected in a dedicated trauma registry.

02

Conditions studied

  • Major Trauma
  • Injuries Major

Browse trials for

Keywords

  • Quality improvement
  • Injury
  • Injuries
03

In context

Wounds and Injuries

5,056 studies on the registry are indexed under Wounds and Injuries; 861 are open to participants now.

This study's enrollment of 1,500 is above the median of 52 across 3,239 interventional studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

This is the only study on the registry with Dr Gerard O'Reilly as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • All patients presenting to any of the four study sites with a potentially life-threatening or limb-threatening injury. Specifically, all presenting injured patients triaged as "Red" or "Yellow" according to the Australia-India Trauma Systems Collaboration (AITSC) Trauma Triage Protocol, will meet the screening criteria for data collection. Retrospective inclusion in the registry will be continued for all screened patients presenting to any of the included hospitals with injury (including near-drowning) as the primary diagnosis and with at least one of the following criteria:

    • Admission to hospital
    • Death after triage but before admission

Exclusion criteria

Exclusion Criteria:

  • The exclusion criteria for the AITSC Trauma Registry are:

    • Death at scene
    • Alive at triage but not admitted to hospital
    • Isolated poisoning
    • Isolated burns
    • Single digit finger or toe amputations
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
1,500 participants (actual)

Study arms

  • No intervention
    Pre-intervention group

    All injured patients to the four intervention sites) and allocated to a red (1st) or yellow (2nd) priority triage category will be eligible for inclusion. The Trauma Quality Improvement Meeting (TQIM) checklist will not be introduced during this phase.

  • Other
    Post-intervention group

    All injured patients to the four intervention sites) and allocated to a red (1st) or yellow (2nd) priority triage category will be eligible for inclusion. The Trauma Quality Improvement Meeting (TQIM) checklist will be used at all Trauma Quality Improvement Meetings (TQIMs)

    Other: TQIM checklist

Interventions

  • OtherTQIM checklist

    The intervention phase will include an intense training period covering: 1. Conduct of Trauma Quality Improvement Meeting (TQIM) (and Trauma Quality Improvement program in general). The training will be delivered using the World Health Organization (WHO) Trauma Quality Improvement Programmes short course and online resources. 2. Implementation of Trauma Quality Improvement Meeting (TQIM) Checklist.

    Also known as: Structured TQI program

06

What researchers measure

Primary outcomes

  1. TQIM Checklist compliance - preventability

    TQIM Checklist compliance - % of cases for which it is agreed that care can be improved

    Time frame: Up to 14 months

Secondary outcomes

  1. TQIM Checklist compliance - corrective action

    TQIM Checklist compliance - % of cases (where it is agreed that care can be improved) for which at least one corrective action is agreed

    Time frame: Up to 14 months

  2. In hospital risk-adjusted mortality

    In-hospital risk-adjusted mortality: The proportion of deaths amongst those with Injury Severity Score (ISS) \>12 and \<50.

    Time frame: Up to 14 months

  3. Hospital length of stay

    Hospital length of stay

    Time frame: Up to 14 months

  4. Time to emergency surgery

    Time from hospital arrival to operating theatre for patients undergoing emergency surgery

    Time frame: Up to 14 months

07

Study locations

4 sites
  • Vadilal Sarabhai Hospital
    Ahmedabad, Gujarat, India
  • Lokmanya Tilak Municipal General Hospital
    Mumbai, India
  • Guru Teg Bahadur Hospital
    New Delhi, India
  • JPN Apex Trauma Centre at All India Institute of Medical Sciences
    New Delhi, India
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 27, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03005509
Lead sponsor
Dr Gerard O'Reilly
Collaborators
National Trauma Research Institute, The Alfred, Monash University, All India Institute of Medical Sciences, New Delhi, The George Institute for Global Health, Australia, Sheth Vadilal Sarabhai General Hospital, Guru Teg Bahadur Hospital, Lokmanya Tilak Municipal Medical College and Hospital, Centralised Accident and Trauma Services, Delhi, India, GVK EMRI: Emergency Management and Research Institute, Maharashtra Emergency Medical Services, India, Nathiba Hargovandas Lakhmichand Municipal Medical College, India, University College of Medical Sciences, India
Responsible party
Dr Gerard O'Reilly (Principal Investigator, National Trauma Research Institute) — Sponsor-investigator
First posted
Dec 29, 2016
Start date
Jan 2017
Primary completion
Mar 2018
Completion
Mar 2018
Last update
Nov 27, 2019

Study contacts

Mark C Fitzgerald, MBBS, MD
principal investigator · National Trauma Research Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion